publication venue for
- Optimization of Metabolic Tumor Volume as a Prognostic Marker in CAR T-Cell Therapy for Aggressive Large B-cell NHL.. 24:83-93. 2023
- Outcomes After Salvage Autologous Hematopoietic Cell Transplant for Patients With Relapsed/Refractory Multiple Myeloma: A Single-Institution Experience.. 23:e182-e189. 2022
- Comparison of Patient Outcomes With Two Different Formulations of Melphalan as Conditioning Chemotherapy for Autologous Hematopoietic Cell Transplantation in Multiple Myeloma.. 23:e85-e96. 2022
- Longitudinal Analysis of Patient-Reported Cognitive Function in Multiple Myeloma.. 22:920-927. 2022
- SOHO State of the Art Updates and Next Questions: Treatment of Older, Vulnerable Adults with Multiple Myeloma.. 22:279-286. 2021
- Disparity in Utilization of Multiagent Therapy for Acute Promyelocytic Leukemia in the United States.. 22:319-325. 2021
- Management of Frail Older Adults with Newly Diagnosed Multiple Myeloma - Moving Toward a Personalized Approach.. 20 Suppl 1:S76-S80. 2020
- Heavy Lifting: Nomenclature and Novel Therapy for Gamma Heavy Chain Disease and Other Heavy Chain Disorders.. 20:493-498. 2020
- Complications Associated With Dose-adjusted EPOCH-rituximab Therapy for Non-Hodgkin Lymphoma.. 18:781-787. 2018